Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$52.09 - $64.1 $2.6 Million - $3.2 Million
49,887 New
49,887 $2.6 Million
Q2 2022

Aug 15, 2022

BUY
$43.0 - $65.64 $3.98 Million - $6.07 Million
92,506 New
92,506 $5.28 Million
Q4 2020

Feb 16, 2021

SELL
$23.34 - $32.22 $678,680 - $936,893
-29,078 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$17.61 - $31.86 $512,063 - $926,425
29,078 New
29,078 $746,000
Q2 2020

Aug 14, 2020

SELL
$14.35 - $26.64 $646,367 - $1.2 Million
-45,043 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$12.31 - $33.12 $818,147 - $2.2 Million
-66,462 Reduced 59.6%
45,043 $692,000
Q4 2019

Feb 14, 2020

BUY
$7.26 - $38.49 $552,769 - $2.93 Million
76,139 Added 215.29%
111,505 $3.83 Million
Q3 2019

Nov 14, 2019

BUY
$7.47 - $14.03 $264,184 - $496,184
35,366 New
35,366 $264,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.85B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.